Home › Cardiovascular Disease › Kansas
Cardiovascular Disease clinical trials in Kansas
17 studies for Cardiovascular Disease are looking for participants at sites in Kansas.
Cities in Kansas
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Hutchinson
- Clinical Trial Site, Kansas City
- Clinical Trial Site, Topeka
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07181109EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- AMR El Dorado, El Dorado
- Cotton O'Neil Diabetes & Endocrinology Center, Topeka
- Tekton Research - Wichita, Wichita
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07064473VDyne TriNova Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
- Ascension Via Christi Hospital, Wichita
Recruiting
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07516444Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Kansas University Medical Center, Kansas City
Recruiting
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT06526195ELEVATE-HFpEF Clinical Study
- University of Kansas Medical Center, Kansas City
Recruiting
Ages 40 and older · All sexes · Updated Nov 3, 2026 · NCT06678841Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- University of Kansas Medical Center, Kansas City
Recruiting
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT03242642Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Midwest Heart and Vascular Specialists, Overland Park
- Kansas Nephrology Physicians, PA, Wichita
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06909565Product Surveillance Registry
- Kansas City
RecruitingObservational study
All ages · All sexes · Updated Oct 20, 2026 · NCT01524276Global Paradise System US Post Approval Study
- Ascension via Christi St. Francis, Wichita
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT06297291A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Kansas City
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 2, 2026 · NCT07333183Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- University of Kansas Medical Center, Kansas City
- VA Eastern Kansas Healthcare System, Topeka
RecruitingPhase 4Healthy volunteers welcome
Ages 75 and older · All sexes · Updated Sep 1, 2026 · NCT04262206A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Kansas City
- Research Site, Kansas City
- Research Site, Topeka
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Hutchinson Clinic PA, Hutchinson
- University of Kansas Medical Center, Kansas City
- Midwest Heart and Vascular Specialists, Overland Park
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012The Oxford Risk Factors And Non-Invasive Imaging Study
- Midwest Heart & Vascular Specialists LLC, Kansas City
- St Luke's Hospital, Kansas City
RecruitingObservational study
Ages 18 to 99 · All sexes · Updated Jul 31, 2026 · NCT05169333PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- University of Kansas Medical Center (KUMC), Kansas City
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT05934487Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
- Midwest Heart and Vascular Specialists, Overland Park
RecruitingPhase 3
Ages 35 to 80 · All sexes · Updated Apr 16, 2026 · NCT07293260Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
- University of Kansas Medical Center, Kansas City
RecruitingPhase 1/2
Ages 35 to 65 · All sexes · Updated Jun 8, 2025 · NCT04715022From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.